Hu, K.; Li, L.; Huang, Y.; Ye, S.; Zhong, J.; Yan, Q.; Zhong, Y.; Fu, L.; Feng, P.; Li, H.
Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging. Pharmaceuticals 2022, 15, 383.
https://doi.org/10.3390/ph15030383
AMA Style
Hu K, Li L, Huang Y, Ye S, Zhong J, Yan Q, Zhong Y, Fu L, Feng P, Li H.
Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging. Pharmaceuticals. 2022; 15(3):383.
https://doi.org/10.3390/ph15030383
Chicago/Turabian Style
Hu, Kongzhen, Li Li, Yong Huang, Shimin Ye, Jiawei Zhong, Qingsong Yan, Yuhua Zhong, Lilan Fu, Pengju Feng, and Hongsheng Li.
2022. "Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging" Pharmaceuticals 15, no. 3: 383.
https://doi.org/10.3390/ph15030383
APA Style
Hu, K., Li, L., Huang, Y., Ye, S., Zhong, J., Yan, Q., Zhong, Y., Fu, L., Feng, P., & Li, H.
(2022). Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging. Pharmaceuticals, 15(3), 383.
https://doi.org/10.3390/ph15030383